Cindy Yu Cindy Yu

Power jab: the rise of vaccine diplomacy

Cindy Yu has narrated this article for you to listen to.

At the end of January the President of Chile, Sebastián Piñera, gave a speech on the tarmac of Santiago airport. ‘Today is a day of joy, excitement and hope,’ he said, standing in front of a Boeing 787 which had just arrived from Beijing. Inside it were two million vaccine doses produced by the Chinese company Sinovac. It was the first of two similar-sized shipments arriving that month.

A few days earlier, the President of Mexico, Andrés Manuel López Obrador, had emerged from Covid confinement to thank a ‘genuinely affectionate’ Vladimir Putin for pledging 24 million Sputnik doses to Mexico in the coming months. Hopes of vaccinating his country with the Pfizer vaccine had dissipated when supply dried up. Pfizer blamed ‘global shortages’, but here was the perfect opportunity for Putin to play the hero and to send the world a message: in times of need, Moscow, not Washington, saves the day.

This is vaccine diplomacy, the new great game. Nations which are hungry to compete with the West — and especially America — are using their homegrown coronavirus vaccines as a way of gaining influence. They are exchanging their vaccines for loyalty and acts of public obeisance.

It’s not that these are world-beating jabs: Sinovac has had some of the lowest efficacy ratings of any licensed vaccinations (only 50.4 per cent in one trial) and was, until this month, not even licensed for general use in China. It’s still not approved for use in the over-sixties, which is perhaps one reason why the Chinese don’t mind hundreds of millions of doses going overseas. On social media, users frequently joke: ‘Other people can have the superior Chinese vaccines. I’ll wait for Pfizer.’ Sinopharm, the other Chinese vaccine producer, can claim 79 per cent efficacy.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.

Or

Unlock more articles

REGISTER

Comments

Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in